3-24-19 BIIB biotech stock down 120 dollars put options 650 % gains
BIIB been trading this stock for 25 years has done this many times over the years and the news hit the headlines we got in big time right away we are still short the names the daily , weekly , charts are huge down trends now as we move forward we will also trade intraday the calls when BIIB comes off the lows. The put charts show you in detail how you could have been in this trade on the gap open down the bottom line.
Biogen downgrade details — to Hold at Canaccord Genuity yesterday; tgt lowered to $275 (219.98 -6.90)
Canaccord Genuity downgraded BIIB to Hold from Buy yesterday while also lowering their tgt to $275 from $396 noting, “On March 21, BIIB/Eisai announced they are stopping Phase 3 trials for aducanumab (early Alzheimer’s disease, AD) for futility as an independent committee said the trials were unlikely to hit their primary endpoints.
Call us today 702-685-0772 watch our site at www.FreeOptionTrader.com JOIN our free events we give by sending us an email then we will reply what day we give out Free Option Trading seminars
Options Trading Education 1,398 videos FreeOptionTrader.com Live Market videos with Live options trading Room
35 years We are the biggest on YouTube with 10 years of live market options entry and exits with our worldwide Option Trading in several countries around the globe